Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Bicycle Therapeutics (BCYC) Times Interest Earned (2021 - 2025)

Bicycle Therapeutics (BCYC) has disclosed Times Interest Earned for 5 consecutive years, with -$1489.8 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Times Interest Earned rose 23.0% year-over-year to -$1489.8, compared with a TTM value of -$1442.9 through Sep 2025, down 1734.79%, and an annual FY2024 reading of -$121.31, down 108.4% over the prior year.
  • Times Interest Earned was -$1489.8 for Q3 2025 at Bicycle Therapeutics, up from -$1603.7 in the prior quarter.
  • Across five years, Times Interest Earned topped out at -$17.37 in Q3 2021 and bottomed at -$1934.7 in Q3 2024.
  • Average Times Interest Earned over 5 years is -$435.0, with a median of -$51.74 recorded in 2023.
  • The sharpest move saw Times Interest Earned grew 25.33% in 2024, then crashed 3463.33% in 2025.
  • Year by year, Times Interest Earned stood at -$21.98 in 2021, then crashed by 77.41% to -$39.0 in 2022, then tumbled by 69.61% to -$66.14 in 2023, then plummeted by 1867.35% to -$1301.2 in 2024, then decreased by 14.49% to -$1489.8 in 2025.
  • Business Quant data shows Times Interest Earned for BCYC at -$1489.8 in Q3 2025, -$1603.7 in Q2 2025, and -$1376.5 in Q1 2025.